Holen Sie sich die Stockscreener-App
8.6154
2.98%
-0.2646
Evolus Inc Aktie (EOLS) Neueste Nachrichten
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future - finance.yahoo.com
Evolus Insider MOATAZEDI DAVID Sells 105,108 Shares at $9.04 Each (NASDAQ: EOLS) - Kalkine Media
Evolus president & CEO David Moatazedi sells $950,018 in shares By Investing.com - Investing.com South Africa
Evolus president & CEO David Moatazedi sells $950,018 in shares - Investing.com India
Evolus Officer Sold Shares Worth Over $950K - TradingView
Insider at Evolus (NASDAQ: EOLS) moves to sell nearly $1M in stock - Stock Titan
Evolus (EOLS) Advances 2.36% to $9.09, Holding Ground Above SupportRange Breakout - dars.gov.et
Evolus (EOLS) adds Soleus group as new 5.3% shareholder - Stock Titan
(EOLS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2 - Eastern Progress
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet - Eastern Progress
Evolus (EOLS) Earnings Update: The EPS Result Is Above Expectation in the Current Update; Market Response: Shares Move Higher 2.22% on the DayEarnings Decline Risk - vinanet.vn
Evolus (EOLS) Results Check: EPS Prints Above Forecast in the Latest Reading; Trading Move - vinanet.vn
EOLS | Evolus, Inc. Common Stock FinancialsRevenue Breakdown - quiverquant.com
Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move - vinanet.vn
Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move: The Share Price Adds 5.28% in the Current UpdatePretax Income Report - dars.gov.et
Evolus (EOLS) Closing Note: Records a 5.28% Increase to $8.18 in the Latest Session; the Price Remains Bounded by the Supplied Support and Resistance in the Available RecordBearish Sentiment - vinanet.vn
EOLS Q2 2026 Earnings: EPS Turns Positive, Delivering 156.82% Surprise vs. EstimatesCost Structure Review - vinanet.vn
August 2026's Leading Growth Companies With Insider Confidence - Sahm
Midday Stock Roundup: Mobix Labs Shares Fall 21% at Midday - ocbj.com
Renaissance Technologies LLC Lowers Stake in Evolus, Inc. $EOLS - marketbeat.com
Evolus, Inc. (EOLS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS - marketbeat.com
EOLS Q2 2026 Earnings: EPS Surprises to the Upside as Shares SlipReturn On Equity - vinanet.vn
Evolus (NASDAQ:EOLS) Reaches New 1-Year HighHere's What Happened - MarketBeat
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade - Yahoo Finance
Evolus: The Injectable Platform Is Becoming The Real Moat (NASDAQ:EOLS) - Seeking Alpha
EOLS Q2 2026 Earnings: EPS of $0.02 Beats Estimates by 156.8% as Profitability Inflection EmergesSpecial Dividend Alert - vinanet.vn
Trading Systems Reacting to (EOLS) Volatility - Stock Traders Daily
Evolus (NASDAQ:EOLS) Rating Increased to Buy at Wall Street Zen - marketbeat.com
Needham Maintains Evolus(EOLS.US) With Hold Rating - moomoo.com
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Evolus Inc (EOLS) Stock News Today - TradingKey
Evolus, Inc. (EOLS) Investor Outlook: Analyzing 97.93% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews
Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Evolus, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:EOLS) 2026-08-06 - Seeking Alpha
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Su - GuruFocus
Earnings call transcript: Evolus tops revenue forecast in Q2 2026, shares rise - Investing.com UK
Evolus, Inc. Q2 2026 Financial Results: Revenue, Risks, and Key Business Updates - Minichart
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ... - Yahoo Finance
Evolus Q2 Earnings Call Highlights - MarketBeat
Is Evolus Inc (EOLS) Undervalued After Q2 Earnings Beat? EPS: -0 - GuruFocus
Evolus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Evolus Q2 2026 slides: profitability streak continues, guidance raised - Investing.com
Evolus, Inc. Q2 2026: Revenue $84.08M, EPS ($0.12) — 10-Q Summary - TradingView
Evolus (EOLS) Releases Q2 2026 Earnings: Revenue Growth and Narrower Losses - Quiver Quantitative
Evolus (Nasdaq: EOLS) posts higher sales and manages sizable debt load - stocktitan.net
Evolus Q2 revenue rises 21%, lifts 2026 outlook - TradingView
Evolus Q2 2026 Earnings: Revenue Rises 21% as Adjusted EBITDA Stays Positive - TradingKey
Evolus (NASDAQ: EOLS) lifts 2026 guidance after Q2 revenue hits $84.1 million - Stock Titan
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook - marketscreener.com
Evolus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Evolus Deadline Alert - TMX Newsfile
Evolus Expands Symatese Partnership into Three New Markets - Orange County Business Journal
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme in Canada, Australia, and New Zealand - marketscreener.com
Evolus expands hyaluronic acid gel rights to three markets By Investing.com - Investing.com Nigeria
Evolus expands hyaluronic acid gel rights to three markets - Investing.com
0.22%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):